




Characterization of Biofilms on Medical Device




Follow this and additional works at: https://tigerprints.clemson.edu/all_theses
Part of the Engineering Commons, and the Microbiology Commons
This Thesis is brought to you for free and open access by the Theses at TigerPrints. It has been accepted for inclusion in All Theses by an authorized
administrator of TigerPrints. For more information, please contact kokeefe@clemson.edu.
Recommended Citation
Macaluso, Amanda, "Characterization of Biofilms on Medical Device Materials with Application to Reusable Surgical Instruments"





CHARACTERIZATION OF BIOFILMS ON MEDICAL DEVICE MATERIALS WITH 









In Partial Fulfillment 
of the Requirements for the Degree 










Melinda K. Harman, Ph.D., Committee Chair 
Sarah W. Harcum, Ph.D. 





















Reusable medical devices or reprocessed single-use devices are original medical 
devices that have been used once and then are cleaned, sterilized, and remanufactured for 
the purpose of an additional single use on a single patient [4]. Improperly reprocessed 
devices are a significant contributor to hospital-associated infections [4]. Challenges that 
hinder reprocessing are related to the complexity of reusable medical device design, the 
necessary validation of cleaning protocols required by the U.S Food and Drug 
Administration (FDA), the impact of human factors throughout the reprocessing cycle, as 
well as economic factors within new business models that are centered on reprocessing.  
Current methods for detecting biofilm accumulation on medical devices are 
established; however, these methods lack appropriate consideration of the complex 
design features of reusable medical devices.  A colorimetric assay widely used for 
quantifying biofilm accumulation is suitable for the complexity of reusable medical 
devices; however, its application has been limited to biofilms grown in tissue culture 
plates, which does not accurately represent the true g owth conditions of biofilm. Both 
material selection and flow conditions are important f ctors that are known to have an 
effect on biofilm formation [15, 23]. The broad objective of this thesis was to deliver a 
simple, cost-efficient method suitable for detecting biofilms on complex reusable medical 
devices in a high-throughput, industry setting for the purpose of validating cleaning 
methods required for reprocessing. Specifically, this esis aimed 1) to grow biofilms 
under static and dynamic conditions, 2) to develop methods to quantitatively assess 
biofilm accumulation using a colorimetric assay and confocal laser scanning microscopy 
 iii  
(CLSM), and 3) to apply these methods on commonly used medical device materials with 
application to reusable surgical instruments.  
Successful completion of these aims demonstrated a modified colorimetric assay 
using crystal violet stain is a highly sensitivity assay that can detect very low 
concentrations of crystal violet eluted from adhered biofilm. The high sensitivity of this 
colorimetric assay makes it ideal for detecting biofilm on reusable medical devices with 
complex design features fabricated from various materi ls. Additionally, it was shown 
that CLSM, in combination with image processing techniques, could yield quantitative 
data for detecting biofilm accumulation by measuring pixilation intensities of biofilm 
with fluorescent staining. Comparing intensity ratios and absorbance measurements from 
the colorimetric assay for a given biofilm could demonstrate a direct relationship between 
the two detection modalities effectively validating the modified colorimetric assay as a 
method for detecting biofilm accumulation on reusable medical devices. This correlation 
would be addressed in future work. 
The modified colorimetric assay presented in this tesis is a highly sensitive assay 
for detecting biofilm accumulation. In this regard, it has potential for improving 
validation methods for cleaning processes required by the FDA for reprocessing reusable 
medical devices. Moreover, its simplicity and high-throughput potential makes it suitable 
for industry applications as it relates to human and economic factors. Ultimately, this 
research work presents a modified colorimetric assay th t offers an innovative solution to 
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1.1 THE GLOBAL MEDICAL DEVICE REPROCESSING MARKET  
The global medical device reprocessing market is currently (2014) estimated at 
$780 million U.S. dollars (USD) and is expected to gr w at a compound annual growth 
rate of 19.3% to become a $2.6 billion USD industry by 2020 [1]. This market is one of 
the fastest growing markets in healthcare today because of three key factors that are 
driving its growth. The first is the demand for reusability to cut healthcare spending. In 
the healthcare industry today the revenue model for pr viders is no longer based on 
throughput alone. As a result, there is a shift towards value-based care in which providers 
can maintain high levels of care without increasing the cost of care. Reusability of 
devices is a value-based care model. The 3,000 U.S. hospitals that are already using 
reprocessed devices see a total savings of $336 million dollars yearly [2]. But, if just 2% 
of single-use devices were reprocessed the healthcare industry would save $2 billion 
USD each year [2]. The second factor that is driving growth is favorable economic 
opportunity. The lower price point of reprocessed dvices compared to original devices 
enables device manufacturers to enter new markets, specifically, the global healthcare 
market [3]. In this regard, reprocessing increases economic opportunity for many original 
device manufacturers. The third factor that is driving growth is environmental 
sustainability. In addition to saving costs, reprocessing is also eliminating waste. The 
healthcare industry is the second largest contributor to landfills in the U.S., generating 
over 4 billion pounds of waste annually [2]. Reprocessing can help hospitals eliminate 
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approximately 9 million pounds of waste each year [1]. The sustainability of reprocessing 
further drives the momentum of this industry.  
While the medical device reprocessing industry is thriving economically, it is not 
without shortcomings.  Improperly reprocessed devices are a significant contributor to 
hospital-associated infections [4]. This chapter will provide an overview of how medical 
device reprocessing works and the microbiological and engineering factors that can 
create challenges for reprocessing.    
 
1.2 A SYSTEMATIC PROCESS   
Medical device reprocessing is a highly regulated, systematic process. In general, 
though, it can be simplified into six distinct phases: collection, inspection, cleaning, 
remanufacturing, sterilizing, and distribution. 1) The process begins with collection at the 
point-of-use of the device in the operating room or clinic. 2) Used devices are properly 
disposed in a designated storage container and later coll cted and transported to either an 
on-site or off-site reprocessing facility. The inspection phase involves visual assessment 
for gross damage. Devices beyond repair are discarded. 3) There the devices that pass 
visual inspection are disassembled for cleaning. A combination of chemical and physical 
processes is required to remove all visible bioburden. 4) The remanufacturing phase 
involves reassembly of the cleaned devices, remanufacturing, and functional testing. 
Many reprocessed devices have sharp blades that may need to be re-sharpened or 
disposable components that need to be replaced. After reassembly and remanufacturing 
the device is tested for function and performance. 5) If the device meets the function and 
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performance specifications, it is then either disinfected or sterilized in accordance with 
FDA requirements.  This choice is dependent upon the degree of risk of infection 
determined by the Spaulding classification system, in which reprocessed devices are 
classified as either critical, intended for contacting sterile body tissues or cavities; semi-
critical, only intended to contact mucous membranes and is not intended to penetrate 
sterile body tissues or cavities; or non-critical, intended for topical contact only [5]. Non-
critical devices require low-level disinfection, semi-critical devices require high-level 
disinfection, and critical devices require sterilizat on. 6) After the device has been 
disinfected or sterilized, it is repackaged and relab ed for distribution.  
 
1.3 COMPLEXITY IN RESUABLE MEDICAL DEVICE DESIGNS 
Reusable medical devices or reprocessed single-use devices are original medical 
devices that have been used once and then are cleaned, sterilized, and remanufactured for 
the purpose of an additional single use on a single patient [4]. Reusable medical devices 
encompass a wide variety of invasive surgical instruments that are used in cardiovascular, 
orthopedic, and general surgical procedures. There are also many non-invasive devices, 
such as pneumatic tourniquet cuffs and pulse oximeter sensors that are reprocessed. 
Though there are a wide variety of reusable medical evices many of these devices have 
similar modes of action and, subsequently, have similar design features. Table 1.1 
provides a broad list of reusable medical devices and key design features. The design 
features commonly associated with these devices are complex, which creates significant 
challenges in cleaning. Some examples include, long and narrow lumens that are 
 4
impossible to fully visualize and confirm complete removal of bioburden, intricate 
cutting teeth and apertures that are difficult to brush, and non-modular components that 
are simply inaccessible for manual cleaning and inspection. Also, many of these devices 
have optics and electrical components that must be considered in both cleaning and 
sterilization techniques, as these components cannot be immersed in cleaning or 
disinfection solutions. In addition to creating difficulties in cleaning and sterilization, 
complex design features provide increased opportunity for biofilm accumulation. Biofilm 
















Table 1.1: Commonly reprocessed reusable medical devices and key design features. 
Reusable medical devices are diverse, but share similar design features that are 
challenging for cleaning.  
 
Reusable Medical Device Key Design Features 
Arthroscopic Shaver 
narrow,long lumens; flexible tubing; 
electrical; ergonomic hand piece; blades 
and burs 
Biopsy Forcep 
narrow, long lumens; blades; angulated and 
straight jaws  
Endoscope 
narrow,long lumens; flexible tubing; 
optics; electrical; ergonomic hand piece  
External Fixation Device 
modular components (i.e nuts and bolts); 
intricate aperatures 
Tourniquet flexible tubing; velcro cuff 
Trocar 
narrow lumens; modular components (i.e 
removable sheaths); blades 
Vessel Sealer 
narrow, long lumen; ergonomic hand 









1.4 BIOFILMS: A CHALLENGE FOR CLEANING AND STERILIZATION  
Potential infection from reprocessed devices is a major concern because of unique 
microbial populations known as biofilms. Biofilms are a diverse, dynamic, and adhered 
microbial population retained within a secreted extracellular polysaccharide (EPS) matrix 
[6]. There are four key physiological characteristic  that differentiate biofilms from 
planktonic or free-floating bacteria. 1) A heterogeneous population of microbial 
organisms within a supporting EPS matrix that provides a three-dimensional hydrated 
structure for the biofilm that can vary in space and time. 2) A differing genetic expression 
from planktonic bacteria makes biofilms impervious to targeted pharmacological 
therapies that have already been established for non-biofilm bacteria. 3) A highly 
developed and coordinated intercellular signaling mechanism, termed quorum sensing, 
enables biofilms to have a controlled, dynamic respon e to the environment. As a result, 
biofilm structure and composition varies widely. 4) A dramatic reduction in susceptibility 
to antibiotics and antimicrobials makes biofilms 1000X more resistant than non-biofilm 
bacteria [6]. Biofilms are protected within in a three-dimensional structure limiting the 
penetration of antimicrobials. Additionally, cells deep within the EPS show reduced 
metabolic activity as a defense mechanism to chemical agents. Overall, the unique 
physiological adaptions of biofilms make them extremely resilient to removal.  
While biofilms are diverse microbial populations, there are certain pathogens that 
are more commonly associated with contaminated surgical instruments. Frequently 
associated with reusable medical devices are Staphylococcus aureus (gram-positive), 
Coagulase-negative Staphylococci (CoNS) (gram-positive), and, Pseudomonas 
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aeruginosa (gram-negative) [7,8].  CoNS are specifically common to reusable surgical 
instruments because these bacteria are normal inhabitants of the skin and mucous 
membranes [9]. CoNS are opportunistic pathogens that have a propensity to form 
biofilms. The most prevalent species of CoNS, accounting for approximately 60-70% of 
all CoNS on the skin, is Staphylococcus epidermidis [9]. 
Biofilm accumulation on reusable medical devices poes a high risk for infection; 
however, the process of biofilm formation can be mitigated if cleaning and sterilization 
occur promptly after use (Table 1.2). Biofilm formation occurs in a gradual process [10]. 
First, reversibly attached microcolonies begin to form where there is a conditioning layer. 
For reusable medical devices this may be urine, blood or some other protenaceous 
substance. Colonizing bacteria then begin to form initial attachments to the 
preconditioned surface. At this point, the biofilm s not fully attached and can easily be 
removed by cleaning. However, if it is not cleaned immediately then irreversible 
attachments will ensue through the production of EPS.  The emerging microbial 
community will continue to grow and develop until it cannot sustain itself. The biofilm 
can then propagate through detachment and dispersal allowing it to reattach to nearby 
surfaces and maintain its viability. Recognizing the potential risk for infection if devices 
are not properly cleaned and sterilized immediately after use, the U.S Food and Drug 
Administration (FDA) has increased regulatory requirements and provided detailed 




Table 1.2: Conditions required for biofilm formation (adapted from Roberts, C.G. 
2013) [19]. This table lists the necessary conditions required for biofilm formation. 
Reusable medical devices provide the conditions necessary for biofilm formation; 
however, irreversible attachment can be prevented if reprocessing steps occur 
immediately after use because the time required for evelopment of a biofilm can be 
controlled.  









yes yes yes 
Surface to be 
colonized yes yes yes 
Sufficient nutrients 





yes yes yes 
Time required for 











1.5 CONSIDERATIONS FOR IMPROVING MEDICAL DEVICE REPROCESSING  
In 2002 the FDA enacted the Medical Device User Fee and Modernization Act 
(MDFUMA), which required manufacturers of reprocessed devices to submit validation 
data for cleaning, sterilization and functional performance [12]. Every reprocessing 
provider must adhere to the standards set forth by t e original device manufacturer 
(OEM) and prove each device can be adequately reproc ssed and meet the standards for 
function and performance. Additionally, MDFUMA requires OEMs to provide proper 
labeling and comprehensive Instructions For Use (IFU) documents to detail the 
reprocessing procedures approved for each specific reusable device. Despite this high 
degree of regulation, the literature reports many reprocessed devices still fail to meet 
reprocessing standards for safety and performance [7,8,11]. For this reason, verification 
and validation of the cleaning, disinfection, and sterilization processes required in 
reprocessing has been a point of discontentment for both OEMs and reprocessing service 
providers in the healthcare industry.  
During the 2011 Medical Device Reprocessing Summit hosted by The 
Association for Advancement in Medical Instrumentation (AAMI) and the FDA, the 
number one call to action focused on improving adequate cleaning validation protocols 
for reprocessing reusable devices [13]. Moreover, in 2011 the FDA also published 
guidelines recommending that human factors be considered in reprocessing validation, as 
human factors are critical for maintaining reproducibility and repeatability of adequately 
reprocessed devices in a high-volume throughput [14]. In order to improve medical 
device reprocessing there are three key factors to be considered: 1) a better definition for 
 10
how “clean” is clean; 2) reusable medical device designs that consider reprocessing from 
the very early stages of device development; and 3) human factors related to reprocessing 
protocols [13].  In addition to these three considerations, there is a fourth indirect 
consideration for improving reprocessing: cost. Theeconomic model of reprocessing is 
not a favorable one for OEMs. Reduction in purchase of new products results in a 
reduction of revenue for the OEM. Consequently, OEMs are neither incentivized to 
design their devices for reprocessing nor are they incentivize to produce feasible 
reprocessing protocols that can be adequately executed in an industrial system. Therefore, 
reducing costs associated with reprocessing for the OEM is another consideration for 





The demand for reusability and the favorable economic environment have driven 
rapid growth in the global medical device reprocessing market.  Consequently, industry 
leaders have recognized key challenges for reprocessing from both clinical and 
engineering perspectives that if improved upon could f rther grow the medical device 
reprocessing industry and yield better reprocessing outcomes. The principle industry 
needs are: 1) improved cleaning validation methods; 2) devices that are designed for 
reprocessing from the very beginning; and 3) reprocessing methods that consider human 
factors and quality control. The broad objective of this thesis is to deliver a simple, cost-
efficient method suitable for detecting biofilms on complex reusable medical devices in a 
high- throughput, industry setting for the purpose f validating cleaning methods required 
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for reprocessing. This broad objective will be achieved through three specific aims: 1) to 
grow biofilms under both static and dynamic flow conditions; 2) to develop methods to 
quantitatively assess biofilm accumulation using a colorimetric assay and confocal laser 
scanning microscopy (CLSM); and 3) to apply these methods to commonly used medical 























Figure 1.1: Thesis aims and outline. The broad objective of this thesis was achieved 
through three specific aims; however, these three sp cific aims were all interdependent, 
as each focused on developing methods for quantification of biofilm accumulation with 
application to reusable surgical instruments. In order to maintain structure in this 
document the thesis aims are discussed in the following manner: Aim I is discussed in 
Chapter 2; Aim II and Aim III, as related to the colorimetric assay, are discussed in 
Chapter 2; Aim II and Aim III, as related to CLSM, are discussed in Chapter 3; and the 













QUANTIFYING BIOFILM ACCUMULATION ON COMMONLY USED  





Quantifying biofilm accumulation on reusable medical devices is necessary for 
validating cleaning methods required for reprocessing; however, increasing complexity in 
device design creates challenges for cleaning. [4]. Many design characteristics related to 
reusable medical devices provide greater opportunities for biofilm growth and 
accumulation. In addition, these design features can hinder manual-cleaning techniques, 
such as brushing, and make visual verification of complete removal of bioburden more 
difficult.   
Methods for assessing biofilm on implantable devices for infection-related 
analyses are already established; however these methods lack appropriate considerations 
for the complex designs of reusable medical devices.  Three principle methodologies 
include the roll plate method, the endoluminal brush technique, and mechanical removal 
for fluorescent staining or biochemical testing [15]. The roll plate method, developed by 
Maki, et al. (1977), assumes bacteria will be recovred by rolling the device onto an agar 
plate [16]. Recovered organisms are then cultured and quantified through cell counting. 
The endoluminal brushing technique, developed by Kite, et al. (1997), follows the same 
premise, but is specific for lumens [17]. Mechanical removal, developed by Donlan, et al. 
(2001), involves sonication of the device to remove biofilm, which is then homogenized 
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to produce a biofilm suspension that can be cultured on an agar plate [18]. Colonies could 
be counted or sub-cultured for fluorescent staining a d biochemical testing.  
These methods were all developed principally for bacteria recovery on 
intravenous catheters to determine associated infection and were validated accordingly. 
However, each of these methods is limited in its applicability to reusable surgical 
devices. The roll plate method is not suitable to devices with complex features such as 
lumens or teeth. Moreover, the study by Maki, et al. (1997) reported 90% of the catheters 
studied had low-density colonization [16].  For this reason, the roll-plate method can 
distinguish infection, but is not reliable for quantifying biofilm colonization due to a low 
percentage of recovered organisms [15]. The endoluminal brushing technique is 
applicable to devices with small diameter lumens; however, it is not feasible for devices 
with large surface areas. Moreover, the endoluminal brushing technique is not suitable for 
intricate design features, such as teeth or modular interfaces.  Mechanical removal of 
biofilm using sonication is a widely used method for quantifying biofilm [15, 19] and has 
proved effective in many cleaning methods [20]; however, this method may not be 
feasible for devices with assembled, optical, or electrical components. Moreover, this 
method cannot localize the regions of biofilm accumulation on the reusable medical 
device. Localization of biofilm accumulation is critical for validating cleaning processes. 
Recognizing the limitations in current methods, there is a clear need for a quantitative 
method for detecting biofilm, specifically on reusable devices, for the purpose of 
validating cleaning methods required for reprocessing.  
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A colorimetric assay using crystal violet (hereinafter CV) is a standard method for 
quantifying bacterial adherence for biofilms grown in polystyrene tissue culture plates 
[21]. The affinity of CV for substances found in the cell walls of bacteria makes CV 
staining a highly sensitive stain for both live and dead cells when compared to the 
previously discussed methods [17]. When used in combination with a decolorizing agent 
that breaks down the lipid structures, the membrane is p rmeabilized, allowing the 
release of CV complexes from the cell walls (Figure 2.1). The released CV can then be 
quantified to determine the amount of adhered biofilm. By measuring the absorbance of 
the released CV a direct relationship between absorbance and bacteria concentration can 
be determined [21]. In this regard, this colorimetric assay is a quantitative method for 
































Figure 2.1: Schematic of bacteria cell wall structures (adapted from Rudolph, K. 
2012) [22]. CV preferentially binds to peptidoglycan in bacteria cell walls, making it a 
unique stain for detecting bacteria. Gram-positive bacteria have cell walls that are 
comprised of approximately 90% peptidoglycan with a t in outer membrane. The outer 
membranes of bacteria cell walls are characterized by high lipid- content, which can be 











While the current recovery methods for detecting biofilm accumulation are well 
established, these methods lack appropriate considerations for the complex design 
features of reusable medical devices (Table 2.1). A colorimetric assay is more suitable 
for complex designs. Additionally, a colorimetric ass y is a highly sensitive method for 
biofilm detection and can localize biofilm accumulation. However, established 
colorimetric assays only assess biofilms grown in a tissue culture plate, which does not 
accurately represent the true growth conditions of bi film. Both material selection and 
flow conditions are important factors that are know to have an effect on biofilm 
formation [15, 23]. These parameters will vary for reusable surgical instruments; 
therefore, material selection and flow conditions must be considered in developing 
methods for detecting and quantifying biofilm accumulation specifically for reusable 
devices. The present study will implement a modifie [23] ASTM method (ASTM 2647-
08) for growing Stapylococcus epidermidis biofilms under dynamic flow conditions in a 
drip flow reactor. The purpose of this study was to mimic relevant biofilm growth 
conditions and modify a colorimetric assay for quantifyi g biofilm accumulation. First, 
biofilms were grown under both static and dynamic conditions on coupons representative 
of four commonly used medical device materials: 316L stainless steel, polycarbonate, 
polypropylene, and silicone rubber. Second, an existing colorimetric assay [21] was 





Table 2.1: Comparison of methods for detecting biofilm on complex reusable 
medical devices. Four methods (discussed above) were compared for suitability in 
detecting biofilm on complex design features of reusable medical devices. In comparison 
to current methods, the CV assay is suitable for detecting biofilms on the most design 
features, while also providing high sensitivity of detection and localization of biofilm 
growth.  
 













long, narrow lumens no yes yes yes 
modular interfaces1 no no yes yes 
blades/jaws2 no no yes yes 
optical devices3 yes yes no no 
electrical devices4 yes yes no no 
large, assembled5 
components  
yes yes no yes 
Degree of Sensitivity low low high high 
Localization of Biofilm 
Growth 
no yes no yes 
 
1modular interfaces refers to the presence of crevices  
2blades/jaws refers to small teeth <1 mm in lateral distance 
3optical devices refers to any device with camera or lens 
4electrical devices refers to any device requiring power to operate 









2.2 MATERIALS AND METHODS  
 
Bacterial species/strains and culture preparation 
 
Staphylococcus epidermidis ATCC 12228 stock cultures were streaked on Tryptic 
Soy Agar (TSA) plates and incubated overnight at 37°C to obtain isolated colonies. A 
single colony was transferred to 30 g/L Tryptic Soy Broth (TSB) media and grown 
overnight in a shaker incubator at 37°C and 125 rpm to either a high (9.68± 0.4 Log10  
CFU/mL) or a low (5.35±0.07 Log10  CFU/mL) inoculum concentration. The overnight 
cultures were used to inoculate the experimental coupons. Stock cultures were frozen in 
1:1 of 20% sterile glycerol and media. Bacteria were r covered in 10 mL of media and 
incubated for 24 h at 37°C.  
 
Coupons and cleaning procedure  
 
Biofilms were grown on 25 x 75 x 1mm coupons, comparable in size to a standard 
glass microscope slide. Coupons were manufactured (Mo el No. DFR-2575, Biosurface 
Technologies, Bozeman, MT) from materials relevant to reusable medical devices: 316L 
stainless steel, polycarbonate, polypropylene, and silicone rubber. 
Prior to use, coupons were cleaned and sterilized. Individual coupons were soaked 
in a 1% enzymatic detergent for 20 minutes, removed and gently cleaned with nylon 
brush for 30 seconds on each side. Coupons were rins d i  tap water and followed by 
sonication (Brunson 5510, Branson Ultrasonics Corporati n, Danbury, CT) in tap water 
for 10 minutes to mechanically remove visible bioburden. Following sonication, coupons 
were rinsed with filter-sterilized water (Milli-Q® Integral Purification System, EMD 
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Millipore, Billerica, MA) to remove any residual detergent. Sonication was repeated in 
filter-sterilized water for 10 minutes. Coupons were steam sterilized for 20 min at 121°C. 
Coupons with any visual evidence of surface damage or defects were discarded.  
 
Dynamic biofilm growth method in drip flow biofilm reactor 
 
Biofilms were grown under dynamic conditions in a drip flow reactor (Model No. 
DFR 110-4, Biosurface Technologies, Bozeman, MT) according to a standard method 
(ASTM 2647-08) previously modified for use with staphylococci by Buckingham-Meyer, 
et al. 2007 [23]. The reactor is designed to accommdate four coupons in 
compartmentalized channels, each with its own influent and effluent ports (Appendix 
B.1). Design of experiment was determined by the constraints of the four channels, which 
is described in Table 2.1. Sterile coupons of each material were placed in the appropriate 
channels. Each channel, containing 15 mL of 30 g/L TSB, was inoculated with 1 mL of 
the S. epidermidis inoculum at either a high (9.68± 0.4 Log10  CFU/mL) or a low 
(5.35±0.07 Log10  CFU/mL) inoculum concentration. Biofilms were initially grown in an 
incubator in batch conditions at a 0° position for 6 h at 37°C. Continuous flow was 
initiated by placing the reactor on a stand oriented at a 10° angle and pumping 3 g/L TSB 
at a flow rate of 0.92 mL/min/channel using a peristaltic pump system (Model No.7553-
80, Cole-Palmer) with four pump heads (Model No. 7518-00, Cole-Palmer) (Appendix 
B.2).  The rate of flow yields a “drip” effect through t e influent valve. The orientation of 
the reactor allows gravitational force to produce a low shear fluid flow over the growing 
biofilm. Biofilms were grown in continuous flow conditions in an incubator at 37°C for 
48 hrs. 
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Static biofilm growth method  
 
Biofilms were grown under static conditions in sterile petri dishes. Sterile 
coupons of each material were placed in sterile petri dishes, each containing 15 mL of 30 
g/L TSB, and inoculated with 1mL of S. epidermidis inoculum at either a high (9.68± 0.4 
Log10  CFU/mL) or a low (5.35±0.07 Log10  CFU/mL) inoculum concentration and grown 
in an incubator at 37°C for 54 hrs. 
 
Experimental design  
 
The modified colorimetric assay was implemented for each material under each 
growth condition. Dynamic and static biofilm growth methods were run in parallel 
yielding a total of eight coupons per experiment. The four-channel capacity of the drip 
flow reactor determined the experimental design. In order to minimize inoculum variation 
and potential channel bias, all four material types w re used in each experimental run and 
each material type was run in each position of the drip flow reactor at least once. Table 
2.2 shows the rotation of each material type through each channel of the drip flow 
reactor. In addition to the variables, material and flow condition, acetic acid volume and 
excitation wavelength were also assessed (Table 2.3). Five replicates of each coupon 
type were grown under both dynamic and static conditions, eluted using 20 mL of acetic 
acid and examined at an excitation wavelength of 492 nm. Two of these replicates were 
also examined at an excitation wavelength of 570 nm. Two replicates of each coupon 
type were grown under both static and dynamic conditions, eluted using 6 mL of acetic 
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acid and examined at excitation wavelengths, 492 nm a d 570 nm. In this manner, a total 










































Table 2.2: Experimental design for testing of four selected materials in drip flow 
reactor.  This design tests all four material types during each experimental run and 
rotates materials through each channel of the drip flow reactor (SS= 316L stainless steel, 
PC= polycarbonate, PP= polypropylene, SI= silicone rubber). Seven replicates for each 













Table 2.3: Experimental design for testing of excitation wavelength and acetic acid 
volume. Excitation wavelength and acetic acid volume were tsted for effects on biofilm 
accumulation in the following manner: coupons from runs 1-5 were examined at 492 nm 
using 20 mL of acetic acid (AA) (n=5) , coupons from runs 4-5 were examined at 570 nm 
using 20 mL of AA (n=2), coupons from runs 6-7 were xamined at 492 nm and 570 nm 
using 6 mL of AA (n=2).  
 
  Tests 
Run  492 nm, 20 mL AA 570 nm, 20 mL AA 492 nm, 6 mL AA 570 nm, 6 mL AA 
1         
2         
3         
4         
5         
6         




  Channel  
Run  1 2 3 4 
1 PP PC SS SI 
2 PC SS SI PP 
3 SI PP PC SS 
4 SS SI PP PC 
5 PP PC SS SI 
6 PC SS SI PP 
7 SI PP PC SS 
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Optical imaging  
Biofilms were imaged using a reflective light optical stereomicroscope (Model 
K400P, Motic, Inc.) and iSolution Lite software at 12X magnification.  
 
Calculation of inoculum broth density  
Inoculum broth density was determined according to methods from Buckingham-
Meyer, et.al 2007 [23]. Inoculation broth was diluted in a serial, ten-fold dilution series. 
Each dilution was plated using the drop plate method where ten drops (10 µl) for each 
dilution were plated on a TSA plate and incubated at 37°C for 24 hrs. Countable drops 
were counted and a mean colony forming unit (CFU) per drop was determined. The 
inoculation broth density was calculated from Equation 1.  
 
Log10 CFU/mL= Log10 [(mean CFU/drop)/0.01ml) x (dilution factor)] (1) 
 
Modification of colorimetric assay method 
A colorimetric assay originally developed for quantifying biofilm accumulation 
on tissue culture plates was modified to quantify bofilm accumulation on the material 
coupons. Biofilms were grown under both static and dynamic conditions according to the 
methods described above. Coupons were carefully remov d from incubation and rinsed in 
filter-sterilized water to wash any planktonic bacteria. Biofilms were heat fixed at 60°C 
for 1 hr. Fixed biofilms were stained with CV (Harleco’s Gram Stain kit, EMD Millipore) 
for 10 minutes. Excess stain was removed by washing in filter-sterilized water until wash 
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solution was clear. Coupons were sonicated (Brunson 5510, Branson Ultrasonics 
Corporation, Danbury, CT) in 20 mL (n=5) and 6 mL (n=2) of acetic acid for 20 minutes 
to elute the stain from the adhered biofilm. A sample volume (200 µl) of the eluted stain 
solution from each coupon was transferred using a multichannel micropipette to a single 
row of wells (n=8) of a sterile, polystyrene 96-well tissue culture plate and read in a 
spectrophotometric microplate reader (Epoch™, BioTek® Instruments, Inc., Winooksi, 
VT) at a wavelength of 492 nm (n=7) and at wavelength of 570 nm (n=4). The eluted CV 
from each coupon was quantified by absorbance.  
 
Statistical analysis 
Effects on the data were analyzed with a generalized n ar model and a binomial 
distribution using statistical analysis software, JMP (JMP 11.0, SAS Institute, Inc., Cary, 
NC) Inoculum concentration, channel position, materi l, flow conditions, excitation 
wavelength, and acetic acid volume were the factors tested for significant effects on the 
variable absorbance (Appendix A).  
 
Crystal violet calibration curve  
In order to determine the range of sensitivity of the spectrophotometric microplate 
reader a CV calibration study was conducted. A 100% CV solution was diluted in acetic 
acid in a series of ten-fold dilution steps, 10%, 1, and 0.1% to produce a calibration 
curve for crystal violet. 200 µl of each concentration was loaded in a 96-well plate and 
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absorbance was measured in a spectrophotometric microplate reader (Epoch™, BioTek® 
Instruments, Inc., Winooksi, VT) at excitation wavelengths of 492 nm and 570 nm. 
 
S. epidermidis biofilm growth curve  
In order to determine a growth curve for S. epidermidis under the previously 
described experimental growth conditions a time study was conducted. Biofilms were 
grown under static conditions in sterile petri dishe  each containing 15 mL of 30 g/L 
TSB. Six glass coupons were inoculated with 1 mL of S. epidermidis inoculum at 9.46 
Log10  CFU/mL (high inoculation broth density). Biofilms were grown at 37°C and 
coupons were removed from incubation sequentially every four hours for 24 hrs. Twelve 
coupons were inoculated with 1 mL of S. epidermidis inoculum at 5.46 Log10  CFU/mL 
(low inoculation broth density). Biofilms were grown at 37°C and coupons were removed 
from incubation sequentially every four hours for 48 hrs. Upon removal from incubation, 
biofilms were fixed at 60°C for 1 hr and biofilm accumulation was measured using the 
colorimetric assay by eluting with 6 mL of acetic acid and measuring absorbance at 492 
nm and 570 nm excitation wavelengths.  
 
Standard curve for absorbance and bacteria concentration  
  
In order to quantify absorbance in terms of bacteria concentration, a standard 
curve was necessary to demonstrate the relationship between these two variables. S. 
epidermidis inoculum at 9.96 Log10  CFU/mL was serially diluted in 30 g/L TSB in a 1:10 
dilution series to achieve 10 dilutions of inoculum. Eleven glass coupons were inoculated 
with 1 mL of each inoculum concentration, including the original stock inoculum (n=11). 
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Biofilms were grown under static conditions in sterile petri dishes each containing 15 mL 
of 30 g/L TSB at 37°C for 24 and 48 hrs. Upon removal from incubation, biofilms were 
fixed at 60°C for 1 hr and biofilm accumulation was measured using the colorimetric 
assay by eluting with with 6 mL of acetic acid and measuring absorbance at a 492 nm 
excitation wavelength.  
 
 
2.3 RESULTS AND DISCUSSION  
 
Verification of biofilm growth under static and dynamic conditions  
 
This study addresses the first aim (Figure 1.1), which was to grow biofilms under 
static and dynamic flow conditions. Two different metrics were applied to verify biofilm 
growth: imaging and consistency in inoculum broth density. Optical stereomicroscope 
images were taken of S. epidermidis biofilms grown under static and dynamic conditions 
on each of the four materials, as well as glass (Figure 2.2). These images qualitatively 
demonstrated biofilm growth on all four materials. Inoculation broth density was 
compared for all seven weeks of data collection to ensure consistency. Figure 2.3 
demonstrates the inoculation broth density for each experimental run. The average 
inoculation broth density for seven experimental runs was 8.4 ± 2.1 Log10  CFU/mL. 
Runs 3 and 7 reported significantly lower inoculum concentration, 5.3 Log10  CFU/mL 
and 5.4 Log10  CFU/mL, respectively. As a result, some variation exists between 
experimental runs; however, statistical analysis confirmed inoculum concentration did 
not have an effect on biofilm growth and subsequent absorbance in the colorimetric assay 
(p>0.05). For this reason, data from all experimental runs, despite low inoculum 
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concentration, were considered in the colorimetric assay analysis. It was important to 
note that both instances of low inoculum broth density were a result of incubator 
malfunction and not of user error or experimental set-up. Moreover, variations within a 
given material type were not dependent upon channel position within the drip flow 
reactor. Statistical analysis confirmed channel position did not have an effect on biofilm 
growth and subsequent absorbance in the colorimetric assay (p>0.05). Overall, these data 


















































Figure 2.2: Optical stereomicroscope images of biofilm. S. epidermidis biofilms grown 
under dynamic conditions on (A) 316L Stainless Steel, (B) Polycarbonate, (C) 
Polypropylene, (D) Silicone, and (E) Glass at 120X magnification (scale bar is 1000 µm 












Figure 2.3: Inoculum broth density. Inoculum concentration (Log10CFU/mL) was 
calculated for each experimental run using Equation 1. The overall average inoculum 
concentration for all experiments was 8.44±2.1 Log10  CFU/mL. This was more 
accurately represented as high and low inoculum concentration groups, where the average 
high inoculum concentration (runs 1, 2, 4, 5, and 6) was 9.68± 0.4 Log10  CFU/mL and 













Modified colorimetric assay:  20 mL acetic acid, 492 nm excitation wavelength  
Aims II and III in this thesis sought to modify a colorimetric assay for quantifying 
biofilm accumulation on various materials exposed to both static and dynamic flow 
conditions (Figure 1.1). The colorimetric assay was originally developed by Christensen, 
et al. (1985) to quantify adherence of clinical staphylococci isolates in a tissue culture 
plate (96-well plate). Bacteria were fixed and stained with CV and the absorbance of 
stained adherent bacteria was measured using a spectrophotometric microplate reader at 
570 nm [21].  In order to accommodate the material coupons tailored specifically for the 
drip flow reactor, the colorimetric assay required modifications. In the modified method, 
use of coupons fabricated from non-opaque materials m de it was necessary to first elute 
the CV stain from adherent biofilm grown on the materi l coupons and then transfer the 
CV stain solution to a 96-well plate, where the absor ance of the eluted solutions of CV 
could be measured using a spectrophotometric microplate reader. Since Christensen’s 
method only considered biofilm grown on the bottom f the well subsequent methods 
have been developed to assess biofilm grown on both the bottom and the walls of the 
well. In this regard, acetic acid has been frequently used in the literature as a solvent to 
elute CV [24]. For the modified colorimetric assay, n appropriate volume needed to be 
determined that would release all bound CV from each biofilm, but not dilute it too 
much. Previous methods that used acetic acid in a 96-well plate applied a 150-200 µl 
volume [24]. This volume was compared to the surface rea of a standard well and 
proportionally applied to the surface area of the sel cted coupons. The modified volume 
of acetic acid determined was 20 mL.  
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An initial qualitative assessment of the modified method illustrated the eluted CV 
solutions were well matched to the amount of adhered biofilm present on each coupon 
(Appendix B.3). Table 2.4 shows the quantitative absorbance data from the modified 
method. It was important to note the absorbance value for polypropylene under dynamic 
conditions appeared to be outlier and a modified Thompson tau test confirmed this. The 
outlier was removed from all further data analysis. F gure 2.4 illustrates absorbance 
values measured at 492 nm for each of the materials under both growth conditions (n=5), 
excluding the outlier. From these data, biofilm accumulation between materials was not 
significantly different (p>0.05). The statistical analysis confirmed that neither material 
selection nor flow conditions had effects on absorbance (p>0.05) at the 492 nm excitation 












Table 2.4: Absorbance of eluted CV solutions in 20 mL of acetic acid at an excitation wavelength of 492 nm (n=5). Five 
replicates of each material type with biofilm grown u der both static and dynamic conditions were examined. Biofilm 
accumulation was detected using the modified colorimetric assay with 20 mL of acetic acid and an excitation wavelength of 
492 nm. Differences in biofilm accumulation on the four materials were not significant under either dynamic (p>0.05) or static 
(p >0.05) conditions. For a given materials type, differences in biofilm accumulation were not significant (p >0.05). 
    Dynamic Static 
  Run Absorbance, 492nm Average Absorbance [nm] Absorbance, 492nm Average Absorbance [nm] 
316L Stainless Steel 1 0.069 0.16±0.06 0.547 0.34±0.20 
  2 0.173   0.351   
  3 0.215   0.145   
  4 0.135   0.519   
  5 0.204   0.136   





Polycarbonate 1 0.091 0.10±0.06 0.114 0.20±0.19 
  2 0.145   0.134   
  3 0.179   0.095   
  4 0.055   0.551   
  5 0.048   0.129   





Polypropylene 1 1.305 0.42±0.49 0.157 0.22±0.13 
  2 0.151   0.344   
  3 0.211   0.064   
  4 0.263   0.375   
  5 0.185   0.175   





Silicone Rubber 1 0.197 0.24±0.15 0.453 0.17±0.16 
  2 0.316   0.167   
  3 0.459   0.064   
  4 0.191   0.107   
  5 0.05   0.075   
Figure 2.4: Absorbance of eluted CV solutions in 20 mL of acetic acid at an 
excitation wavelength of 492 nm (n=5). Graphical data excludes the outlying 
absorbance value, 1.305, for polypropylene under dynamic conditions in Run 1. This 
value was confirmed an outlier from the modified Thompsons tau test. These data 
demonstrate variation in biofilm accumulation for each material under both static and 
dynamic conditions. Differences in biofilm accumulation on the four materials were not 
significant under either dynamic (p>0.05) or static (p >0.05) conditions. For a given 
materials type, differences in biofilm accumulation under static and dynamic conditions 








The statistical analysis concluded these parameters did not impact biofilm 
behavior drastically enough to result in differences in biofilm accumulation. However, 
these two parameters are well characterized in their influence on biofilm behavior.  
Material characteristics, specifically surface roughness and surface energy, are well 
understood in their effect on biofilm adherence [15]. Generally, rougher more 
hydrophobic materials will develop biofilms that are more strongly adhered [15] while 
the opposite is true for smoother hydrophilic materi ls [15]. Fluid flow conditions are 
also well understood in their effect on biofilm adhesion. Pereia, et.al (2002) conducted a 
fluid flow analysis for Pseudonomas fluorescens biofilms under both turbulent flow 
(Re=5500, fluid velocity 0.5 m s-1) and laminar flow (Re=2000, fluid velocity 0.2 m s-1) 
conditions and observed distinct differences in biofilm architecture [25]. Biofilms grown 
under laminar fluid flow conditions will be thicker as nutrient acquisition is facilitated in 
these conditions, yet less dense due to sloughing. Biofilms will eventually reach a 
saturation point in thickness and will slough off in order to maintain viability. For this 
reason, biofilms in laminar flow conditions will be l ss resistant to detachment [25]. 
Biofilms grown under turbulent fluid flow conditions respond to the hydrodynamic 
stresses through increased production of EPS, which increases adhesion of the biofilm to 
its substrata [25]. Recognizing that both material selection and fluid flow conditions are 
known to have an effect on biofilm accumulation, these data from the current study were 




Modified colorimetric assay: 20 mL acetic acid, 570 nm excitation wavelength  
It was observed that absorbance values were very low in comparison to data 
reported in the literature [21]. It was, therefore, hypothesized that the CV concentration 
was not in the most sensitive range of absorbance for the 492 nm excitation wavelength. 
Using the CV calibration curve,  the sensitivity of the spectrophotometer microplate 
reader at both 492 nm and 570 nm excitation wavelengths was determined for various CV 
concentrations. Figure 2.5 shows at 492 nm there is a higher degree of sensitivity for 
high CV concentrations (>1%), while at 570 nm there is a higher degree of sensitivity for 
low CV concentrations (<1%). Recognizing that low levels of biofilm accumulation may 
be better detected at the 570 nm excitation wavelength, the 570 nm excitation wavelength 
was incorporated in the colorimetric analysis along with 492 nm. Table 2.5 shows 
absorbance data for experimental runs 4 and 5 excited at 570 nm. From these data, 
differences in biofilm accumulation remained insignificant. Statistical analysis concluded 






Figure 2.5: Crystal violet calibration curve. CV was diluted in acetic acid to achieve a 
series of ten-fold dilution steps, 10%, 1% and 0.1% to produce a calibration curve for CV 
concentration at excitation wavelengths of 492 nm ad 570 nm. At 492 nm, the most 
sensitive range of detection is between 1% and 10% CV concentration. Whereas, at 570 











Table 2.5: Absorbance of eluted CV solutions in 20 mL of acetic acid at an excitation 
wavelength of 570 nm (n=2). Two replicates of each material type with biofilm grown 
under both static and dynamic conditions were examined. Biofilm accumulation was 
detected using the modified colorimetric assay with 20 mL of acetic acid and an 
excitation wavelength of 570 nm. Differences in biofilm accumulation on the four 
materials were not significant under either dynamic (p>0.05) or static (p >0.05) 
conditions. For a given material type, differences in biofilm accumulation under static 












    Dynamic Static 
  Run Absorbance, 570nm Absorbance, 570nm 
316L Stainless Steel 4 0.717 3.45 
  5 1.47 0.998 
        
Polycarbonate 4 0.137 3.52 
  5 0.124 0.823 
        
Polypropylene 4 1.67 2.63 
  5 1.72 1.51 
        
Silicone Rubber 4 1.09 0.538 
  5 0.123 0.375 
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Modified colorimetric assay: 6 mL acetic acid, 492nm and 570nm excitation wavelengths 
A third approach was implemented in an effort to improve the modified 
colorimetric assay for detecting difference in biofilm accumulation grown under static 
and dynamic conditions on the selected materials. It was hypothesized that too much 
acetic acid would dilute the CV solution and obscure the data, thereby, making it difficult 
to discern differences in biofilm accumulation. This approach, therefore, proposed a 
decrease in the volume of acetic acid used to eluteCV from adhered biofilm. Table 2.4 
reports the highest absorbance value to be 1.305. This absorbance value corresponded to 
a CV concentration of 3%, according to the CV calibr tion curve (Figure 2.5). A 3% CV 
concentration in 20 mL of acetic acid indicated 0.6 mL of CV was taken up by the 
biofilm.  In order to optimize the detection of CV, it was necessary to have a target CV 
concentration within the range of high sensitivity. For a 492 nm excitation wavelength, 
this was a 10% CV concentration (Figure 2.5). Therefore, assuming the volume of CV 
uptake by the biofilm was constant, 0.6 mL, only a 6 mL volume of acetic volume would 
be needed. Table 2.6 provides absorbance data for experimental runs 6 and 7, which used 
6 mL of acetic acid, at excitation wavelengths 492 nm and 570 nm, respectively. In these 
data, statistical analysis reported that excitation wavelength did have an effect on 
absorbance (p<0.05). Detection of biofilm was improved when the volume of acetic acid 
was decreased, resulting in increased concentrations of CV.  The increase in CV 
concentrations shifted the range of detection in the regions on the CV calibration curve 
where absorbance was most sensitive. Figure 2.6 confirmed the excitation wavelengths 
had distinct regions of high sensitivity. Consequently, it was likely for wavelength to 
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have an effect when CV concentrations fell within those distinct regions. Despite the 
increase in sensitivity, differences in biofilm accumulation between materials were not 
significant (p>0.05). Statistical analysis of these data confirmed material selection and 
flow conditions remained not significant in their effect on absorbance (p>0.05). However, 
due to the low sample size for each material the power for detecting significant 
differences is also low (β<0.8). Consequently, if there were significant differences in 




Table 2.6: Absorbance of eluted CV solutions in 6 mL of acetic acid at excitation wavelengths of 492 nm (n=2) and 570 
nm (n=2). Two replicates of each material type with biofilm grown under both static and dynamic conditions were examined. 
Biofilm accumulation was detected using the modifie colorimetric assay with 6 mL of acetic acid and excitation wavelengths 
of 492 nm and 570 nm.  Differences in biofilm accumulation on the four materials were not significant u der either dynamic 
(p>0.05) or static (p >0.05) conditions. For a given materials type, differences in biofilm accumulation under static and 
dynamic conditions were not significant (p >0.05). 
 
    Dynamic Static Dynamic Static 
  Run Absorbance, 492nm Absorbance, 492nm Absorbance, 570nm Absorbance, 570nm 
316L Stainless Steel 6 0.583 0.445 3.650 3.466 
  7 0.307 2.375 2.721 3.987 





Polycarbonate 6 0.187 0.234 1.306 2.225 
  7 0.094 0.849 0.484 3.646 




Polypropylene 6 0.275 0.374 1.962 3.355 
  7 0.120 1.134 0.895 3.702 





Silicone Rubber 6 0.156 0.111 0.878 0.800 
  7 0.065 0.107 0.275 0.725 
 
Biofilm growth curve  
In summary, modifications to both excitation wavelength and acetic acid volume 
in the colorimetric assay did not result in significant differences in biofilm accumulation 
between each material. However, a 6 mL volume of acetic acid and a 570 nm excitation 
wavelength provided a highly sensitive method for detecting biofilm accumulation. 
Recognizing the modifications of the colorimetric ass y were suitable for detecting low 
concentrations of biofilm and did not require further modification, biofilm growth 
methods were investigated.  
A plausible explanation for the lack of significant differences in biofilm 
accumulation, unrelated to the modifications of the colorimetric assay method, was 
biofilm growth saturation. Biofilms are well understood in their growth patterns. 
Generally, biofilms exhibit four phases of growth: 1) lag, 2) exponential, 3) stationary, 
and 4) death [26]. The lag phase occurs immediately fter inoculation and persists until 
the bacterial population is acclimated to the environment. At this point, cell growth 
proceeds at an exponential rate, hence the exponential phase. The growing bacterial 
population doubles at regular intervals until nutrients become limiting or toxic products 
begin to accumulate, which is when the bacterial population enters the stationary phase. 
During the stationary phase, there is no net cell growth. Finally, the cells begin to lose 
viability and enter the death phase [26]. Therefore, if biofilm growth during the current 
study had reached the stationary phase and was not changing, differences in biofilm 
accumulation on the various materials would be difficult to discern.  It was, therefore, 
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hypothesized that the biofilm growth period of 54 hrs was too long and resulting biofilms 
were in the stationary phase of growth.  
Based on the results from the S. epidermidis biofilm growth curve generated using 
high and low inoculation broth densities, the time duration to initiate the stationary 
growth phase was determined. Figure 2.6 confirmed that biofilms inoculated with the 
high inoculation broth density were saturated after 8 h s of static growth and Figure 2.7 
confirmed that biofilms inoculated with the low inoculation broth density were saturated 
after 16 hrs of static growth.  These growth times are considerably lower than the 54 hrs 
used to generate the data in the current study. The 54 hr incubation time specified by 
Buckingham-Meyer, et al. (2007) was necessary for gr wing a robust biofilm needed for 
determining efficacy of disinfection solutions. This thesis, however, aimed to develop a 
method for detecting biofilm accumulation post cleaning processes. In this regard, the 
duration of biofilm growth should be less than 16 hrs in order to detect low levels of 
biofilm accumulation on the materials. Further research is needed to determine the 
biofilm growth curve for each of the materials so that the appropriate time point for 










Figure 2.6: S. epidermidis biofilm growth over 24 hrs with a high inoculation broth 
density. Biofilms grown on glass coupons under static conditions. Coupons were 
removed from incubation every 4 hrs and biofilm accumulation was quantified using the 
modified colorimetric assay with 6 mL of acetic acid. At both excitation wavelengths, 













Figure 2.7: S. epidermidis biofilm growth over 48 hrs with a low inoculation broth 
density. Biofilms grown on glass coupons under static conditions. Coupons were 
removed from incubation every 4 hrs and biofilm accumulation was quantified using the 
modified colorimetric assay with 6 mL of acetic acid. At both excitation wavelengths, 












Standard curve for bacteria concentration and absorbance  
In order to quantify absorbance in terms of bacteria concentration, a standard 
curve was necessary to demonstrate the relationship between these two variables. Figure 
2.8 demonstrates the relationship between bacteria concentration and absorbance for a 
biofilm grown over 24 hrs and 48hrs. These data confirm a linear relationship between 
absorbance and bacteria concentration for concentrations in the range of of 7-9 
Log10CFU/mL. For all concentration less than this range, absorbance is relatively 
constant. This is important to note for biofilms inoculated with the low inoculum 
concentration (<6 Log10CFU/mL) during runs 3 and 7 (Figure 2.3). A standard curve 
representing biofilms grown for shorter time periods, as discussed previously, is likely to 
demonstrate a linear relationship between absorbance d bacterial concentration for 
lower concentrations, as well. Moreover, the bacteria concentrations in Figure 2.8 reflect 
the inoculum concentration and not the concentration at the end of the growth period. 
These data could be improved upon in future work by centrifuging and serially diluting 
the cells at the end of the growth period to determine the exact bacterial concentration at 
that point in time. Determining the relationship betw en absorbance and bacteria 









Figure 2.8: Standard curve for bacteria concentration and absorbance. Bacterial 
solutions were serially diluted and then cultured on glass coupons for 24 or 48 hrs. 
Biofilm accumulation was assessed using the modified colorimetric assay using 6 mL of 
acetic acid at a 492 nm excitation wavelength. A linear relationship between bacteria 
concentration and absorbance was observed for high concentration, 7-9 Log10 CFU/mL.  
 
 
2.4 CONCLUSION  
  An established colorimetric assay for quantifying biofilms adherence to tissue 
culture plates was proposed as a valid method for verifying cleaning procedures required 
for reprocessing.  However, parameters that are known t  impact biofilm accumulation, 
material selection and fluid flow conditions, have not been previously considered in 
colorimetric assays for detecting biofilm. This chapter demonstrated modifications 
required for this assay to adequately quantify biofilm grown on large surface areas. From 
experimental data, it can be concluded that a 6 mL volume of acetic acid and a 570 nm 
excitation wavelength together provide a highly sensitive detection method for biofilms 
stained with CV. The high sensitivity of this colorimetric assay makes it ideal for 
detecting biofilm on reusable medical devices with complex design features.  
Despite the high degree of sensitivity of the colorimetric assay, significant 
differences in biofilm accumulation between materials were not observed. The biofilm 
growth curve demonstrated that in order to detect significant differences in biofilm 
accumulation on the various materials, biofilm growth time should be reduced to 8 hrs or 
less. Further data is needed to determine if significant differences in biofilm 
accumulation on the different materials can be detect d using the 8 hr incubation time.  
In conclusion, the experimental work presented in th s study confirmed that the 
modified colorimetric assay is a high sensitivity ass y with potential to detect biofilm 
accumulation on reusable medical devices. The findings n this study also show that 
while material selection and flow conditions may not have an effect on biofilm 
accumulation, biofilm growth conditions do as well. In this regard, for future work it 
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would be important to assess variation in biofilm growth conditions, such as time, and 





























Confocal laser scanning microscopy (CLSM) is an imaging technique used for 
obtaining high-resolution optical images at various depths of a sample to generate 3D 
reconstructions. CLSM is advantageous for biofilm imaging because it can provide real-
time analysis of biofilm in a natural, hydrated state. In this regard, biofilm structure can 
be preserved providing enhanced understanding of spatial heterogeneity, architecture, and 
morphology. In addition, thin optical sectioning of the biofilm can semi-quantitatively 
assess variations in biovolume, thickness, and viability, when appropriately labeled. 
Confocal imaging has been used extensively for studying variations in biofilm in 
differing physical and chemical environments for a variety of applications [27].  
While confocal imaging has been primarily a semi-quantitative method for 
investigating biofilm structure, developments in image processing have refined 
quantitative outputs from CLSM images [27, 28, 29]. Using image-processing software, 
such as Image J (National Institutes of Health), pixilation intensities of biofilm with 
fluorescent staining can be quantified. The previous chapter discussed the development of 
a modified colorimetric assay and its potential application in cleaning protocols required 
for reprocessing reusable medical devices.  Recall, the colorimetric assay utilizes a 
crystal violet stain that binds to bacteria cell wals of both live and dead bacteria and the 
amount of crystal violet bound to adhered biofilm can be quantitatively assessed through 
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absorbance. Comparing absorbance measurements and inte sity ratios for a given biofilm 
could demonstrate a direct relationship between the colorimetric assay and confocal 
imaging effectively validating the modified colorimetric assay as a method for detecting 
biofilm accumulation on reusable medical devices.   
However, in order to obtain accurate quantitative data, fluorescent imaging 
techniques for biofilms needed to be optimized.  Though there are many published 
methods for imaging biofilm using CLSM, there are few that observe biofilm grown on 
non-transparent materials. Scanning electron microscopy (SEM) is a commonly used 
imaging modality because it can provide high-resoluti n images of cellular morphology 
on non-transparent materials. However, because SEM requires fixation it can alter 
structure and cellular spatial variation within thebiofilm [30].  Implementation of a glass 
interface, whether through cover slipping or a glass-bottom petri dish, has been shown to 
be an effective method for CLSM imaging of biofilm on non-transparent materials [31]. 
The objectives of this study were to demonstrate imaging processing of fluorescent 
intensities as a means to quantify biofilm accumulation and to optimize biofilm imaging 













3.2 MATERIALS AND METHODS 
 
 
Bacterial species/strains and culture preparation 
 
Staphylococcus epidermidis ATCC 12228 stock cultures were streaked on Tryptic 
Soy Agar (TSA) plates and incubated overnight at 37°C to obtain isolated colonies. A 
single colony was transferred to 30 g/L Tryptic Soy Broth (TSB) media and grown 
overnight in a shaker incubator at 37°C and 125 rpm to a high inoculum concentration of 
approximately 9 Log10  CFU/mL. The overnight cultures were used to inoculate the 
experimental coupons. Stock cultures were frozen in 1:1 of 20% sterile glycerol and 
media. Bacteria were recovered in 10 mL of media and incubated for 24 h at 37°C.  
 
Live/Dead assay verification on glass-bottom fluorodishes 
 
A glass-bottom fluorodish (Model No. FD35-100, World Precision Instruments, 
Inc., Sarasota, FL) was inoculated with 1 mL of S. epidermidis inoculum at a high 
inoculum concentration of approximately 9 Log10  CFU/mL and incubated overnight at 
37°C. Biofilm was stained with a fluorescent viability stain (FilmTracer™ 
LIVE/DEAD® Biofilm Viability Kit, L10316, Invitrogen) according to the 
manufacturer’s instructions. Biofilms were excited with a white light laser at 480 nm and 
535 nm excitation wavelengths using a 63X oil-immersion lens (HcPl APO CS2 NA1.4) 





Cover slipping verification on rectangular glass coupons  
The edges of glass coupons (25 x 75 x 1 mm) were first masked with Teflon tape 
to prevent biofilm growth where the coverslip would later be adhered. Coupons were 
placed in sterile petri dishes, each containing 15 mL of 30 g/L TSB. Coupons were 
inoculated with 1 mL of S. epidermidis inoculum at a high inoculum concentration of 
approximately 9 Log10  CFU/mL and incubated at 37°C for 48 hrs. Coupons were 
removed and rinsed in filter-sterilized water to remove any planktonic cells. Biofilms 
were stained with a fluorescent viability stain (FilmTracer™ LIVE/DEAD® Biofilm 
Viability Kit, L10316, Invitrogen) according to the manufacturer’s instructions. The 
Teflon tape was removed and glass coverslips were affix d using Valup wax. Biofilms 
were excited with a white light laser at 480 nm and535 nm excitation wavelengths using 
a 63X oil-immersion lens with the Leica TCS SPE (Leica Microsystems, Buffalo Grove, 
IL) and a 20X lens with the Leica SP8X-MP confocal microscope (Leica Microsystems, 
Buffalo Grove, IL). Various laser, stitching, and Z stack configurations were applied for 
determining optimal image settings for cover-slipped biofilms.  
 
3.3 RESULTS AND DISCUSSION  
Biofilms were initially grown and imaged in a glass-bottom fluorodish to provide a 
standard for comparison to biofilms grown on non-transparent materials and imaged 
using a cover slipping method. Biofilms were stained with a viability stain using syto 9 
and Propidium Iodide labels. Syto 9 is a DNA binding dye that indicates live cells 
through green fluorescence emission, while propidium iodide is a DNA binding dye that 
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only penetrates permeabilized membranes and indicates dead or dying cells through red 
fluorescence emission. 3D reconstructions of the biofilm demonstrated a biofilm 
approximately 40 µm thick (Figure 3.1-A, B). Additionally, the maximum intensity 
projection image in Figure 3.1-C showed high pixel intensities (orange/yellow pixels) 
throughout the biofilm. This result indicated a well-formed and spatially diverse biofilm 
and provided preliminary verification of the staining and imaging techniques. 
Aim II (Figure 1.1) of this thesis sought to develop methods for quantitatively 
assessing biofilm accumulation using CLSM. To achieve this aim, individual slices of the 
3D reconstruction were analyzed using image processing oftware, ImageJ. High-
resolution, RGB images from each fluorescent channel were captured and converted to 8-
bit grey scale images. Background fluorescence was subtracted from each grey scale 
image using the Rolling Ball method at a 10-pixel radius. The Otsu Threshold method 
was applied to detect edges in intensity to create a binary mask for both live and dead 
channels. The binary mask is a black and white image where black pixels represent signal 
and white pixels represent no signal (Figure 3.2). From the binary mask, pixels were 
counted as regions of interest (ROI) to determine cell counts and percent area of cell 
coverage. Percent area was calculated based on the average size of the ROI. ROI size 
varied from large clumps to discrete particles as aresult of staining (Figure 3.2). The 
quantitative outputs for a single slice at 9.9 µm are shown in Table 3.1.  There were 
significantly more live cells than dead cells, 1,923 and 908, respectively. Considering 
area coverage, live bacteria covered 82% of the defined 200 µm x 200 µm area, while 
dead bacteria only covered 18% of the defined area. Overall, these data confirmed the 
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image processing methods were an accurate method to quantify cell counts within a 3D 
biofilm sample. These data could be obtained for the entire 3D stack through automated 



























































Figure 3.1: 3D CLSM images of S. epidermidis biofilm at 63X magnification on 
glass-bottom fluorodish. A) and B) 3D Z-stacks of biofilm stained with BacLight 
viability assay that labels live cells green and dead cells red. C) A maximum intensity 
projection of z-stack highlights presence of high intensity pixels in variations of orange 
and yellow. Image scale is 200 µm x 200 µm. 
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Figure 3.2: Processed CLSM images of S.epidermidis biofilm at 9.9 µm. CLSM 
images were converted to binary (black and white) images using ImageJ software. (Top) 
Initial and binary images of live bacteria cells stained with syto 9. (Bottom) Initial and 
binary images of dead bacteria cells stained with propidium iodide. Image scale is 200 µm 







Table 3.1: S. epidermidis biofilm cell quantification at 9.9 µm slice of CLSM 3D Z-
stack. Image processing outputs yield a total particle count of 2,831 cells with 68% being 
live cells and 32% being dead cells. Considering the variation in size of the ROI, % area 
of cell coverage for 200 µm x 200 µm area was also determined. Live cells covered 82% 
of the defined area, while dead cells covered 18% of the defined area.  
 
Slice Count % Cells 
Average Size of 
ROI Total Area % Area 
Live 1,923 68 1,327,207 2,552,218,241 82 
Dead 908 32 635,744 57,725,591 18 
Total 

















Aim III ( Figure 1.1) of this thesis sought to apply imaging methods for bi films on 
non-transparent materials. In this regard, various techniques were implemented to obtain 
optimal biofilm images. In order to image biofilms on non-transparent materials a cover 
slip is required to provide a glass interface for light transmission to the sample. To 
adequately adhere the cover slip to the coupon without compressing the biofilm, Teflon 
tape was first applied to the coupon to mask biofilm growth. Prior to imaging, the Teflon 
tape was removed and Valup wax was applied to affixthe edges of the glass cover slip to 
the coupon. While the tape and wax method did improve adherence of the coverslip and, 
subsequently, focus, there were two distinct challenges associated with this method. First, 
placement of the coverslip in a perfect, level orientation was difficult. As a result, there 
was a “tilt effect” which caused variation in detected intensity throughout the sample. 
Laser settings should be optimized for a given biofilm based on the staining method and 
substrate material.  However, when scanning in the z-plane those specified settings were 
not captured when there were changes in the z distance between the coverslip and the 
biofilm. This variation resulted in loss of signal and, subsequently, gaps in the detected 
intensity.  Figure 3.3 demonstrates the gaps in detected intensity signal n both the green 
and red fluorescent panels where there was no detection in the 0-60 μm region in the x-
direction and then apparent detection in the 60-200 μm region in the x-direction. For 





Figure 3.3: 4 x 4 tile scans of S. epidermidis biofilm on rectangular glass coupon at 
63X magnification. A) Syto 9 fluorescent label (live cells) B) Propidium Iodide 
fluorescent label (dead cells). C) Differential interference contrast image D) Overlay of 






The images shown in Figure 3.3 were taken as an automated stich of a 4 x 4 tiled 
region within the biofilm sample. It was thought that reducing the area of the tiled region 
would mitigate the “tilt” effect. Figure 3.4 shows a 3 x 3-stitched region where improved 
detection was observed. However, this image introduce  another observed artifact: “the 
puzzle piece effect.” Stitching is a way to automate image capture so that a statistically 
significant region of the biofilm can be analyzed. This method ensures imaging of regions 
in the middle, as well as regions on the edges of the biofilm. However, because the 
biofilm sample was sparse and non-uniform the software did not have an accurate frame 
of reference to stich the correct pixels. Figure 3.4 shows severe discontinuity in the third 
tiled region.  Discontinuity in the stitch would make it difficult to accurately 
quantitatively assess the biofilm. To address these two challenges biofilm samples were 
imaged at a lower magnification, 20X. A lower magnification would result in less distinct 
morphology, however, it would allow capture of a large region without having to modify 
laser settings, thereby, potentially reducing the eff ct of the cover slip tilt and the 
discontinuity in stitching. Despite this, biofilm iaged at 20X showed significant 
artifacts in the intensity in both the green and red fluorescent panels, as shown in F gure 
3.5.  Intensity variation could be observed even within a single tiled region of biofilm. 
Overall, these methods resulted in poor quality images with intensity artifacts that would 








Figure 3.4: 3 x 3 tile scans of S.epidermidis biofilm on rectangular glass coupon at 
63X magnification. A) Syto 9 fluorescent label (live cells) B) Propidium Iodide 
fluorescent label (dead cells). C) Differential interference contrast image D) Overlay of 










































Figure 3.5: 5x5 tile scans of S.epidermidis biofilm on rectangular glass coupon at 
20X magnification, A) Syto 9 fluorescent label (live cells) B) Propidium Iodide 
fluorescent label (dead cells). Scale bar is approximately 50 µm. C) Overlay. Each 






3.4 CONCLUSION  
A step-wise approach for optimizing imaging techniques was used to image biofilms 
on non-transparent materials, quantify the amount of bacteria cells present throughout a 
full-thickness biofilm, and localize the live/dead cells relative to the coupon substrate.  
Using publically-available imaging software (ImageJ) and common image processing 
techniques for thresholding and masking, it was possible to determine percent area of cell 
coverage within the biofilm distributed over the sub trate surface area. Overall, the image 
processing methods were suitable for quantifying cell counts within a 3D biofilm sample 
and could be used to gain quantitative information related to total biofilm accumulation.  
While an optimal method for imaging biofilm on rectangular glass coupons was not 
defined, this approach generated a clearer understanding of the realities of biofilm 
imaging using CLSM. Glass-bottom dishes provided a us ble interface for imaging 
biofilm on non-transparent materials without disrupting the film, whereas, cover slipping 
was cumbersome and resulted in many image artifacts. A proposed solution for 
optimizing biofilm imaging techniques on the material coupons described in this thesis is 
to redesign the rectangular coupons machined for the drip flow reactor to a more suitable 
configuration for a glass-bottom fluorodish. Optimal ethods for imaging biofilms on 
non-transparent materials are necessary for obtaining accurate quantitative data for 
assessment of biofilm accumulation. Proof of-concept data showed that image processing 
of biofilms could quantify pixilation intensities to determine biofilm accumulation. This 
data could be used in the future to validate the colorimetric assay for detecting biofilm 
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accumulation for high-throughput industry validation methods for cleaning of reusable 




































CHAPTER FOUR  
 
ENGINEERING AND COMMERCIAL SIGNIFICANCE 
 
4.1 INTRODUCTION  
The broad objective of this thesis was to deliver a simple, cost-efficient method 
suitable for detecting biofilms on complex reusable m dical devices in a high-throughput 
industry setting for the purpose of validating cleaning methods required for reprocessing. 
The purpose of this chapter is to demonstrate the significance of the broad objective as it 
relates to improved outcomes of medical device reprocessing.   
Engineers seek to design for function and performance of their product. End-user 
needs are identified and designs are manifested to meet those needs. For reusable medical 
devices, the paradigm for device design should not solely concern function and 
performance. Instead, design decisions need to concern reducing biofilm accumulation 
and improving feasibility for cleaning. As discussed in Chapter 1, reusable medical 
device designs should consider reprocessing from the very early stages of device 
development. The first objective of this chapter is to demonstrate the impact of design 
considerations, such as geometry and surface texture, on biofilm accumulation and the 
resulting implications for medical device reprocessing outcomes.  The second objective 
of this chapter is to demonstrate the colorimetric assay as a simple, inexpensive method 






4.2 DESIGN CONSIDERATIONS FOR REUSABLE MEDICAL DEVICES  
 
Geometry and fluid flow phenomena 
The behavior of fluid flow can be described as either laminar or turbulent. At low 
velocities fluids tend to flow without lateral mixing and there are no crosscurrents or 
eddies [32]. This flow regime is described as laminar. At higher flow velocities mixing 
does occur resulting in crosscurrents and eddies. Thi  flow regime is described as 
turbulent [32]. The conditions under which fluid flow transitions from the laminar regime 




               (1) 
 
where  D = diameter of the tube 
V = average linear velocity of the liquid 
 ρ = density of the liquid 
 μ = viscosity of the liquid 
 
Flow is always within the laminar regime for Reynolds numbers less than 2,100 and 
within the turbulent regime for Reynolds numbers greater than 2,100 [32].  
As discussed in Chapter 2, many reusable surgical devices will operate under flow 
conditions. A principle example is the flexible endoscope. Flexible endoscopes have been 
used in minimally invasive surgery since the 1960s [33]. However, it wasn’t until 1988 
that the American Society for Gastrointestinal Endoscopy in conjunction with the 
American College of Gastroenterology published the first guidelines for cleaning and 
disinfection of GI endoscopes [33]. Flexible endoscopes have unique designs, which 
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make them especially challenging for reprocessing. Consequently, they have been studied 
extensively in regard to cleaning methods.  
There are a wide variety of flexible endoscopes that are specified for many 
different surgical applications. Some flexible endosc pes are used only for viewing and 
diagnostic purposes, while some are designed with conduits for laparoscopic instruments. 
Despite the variety in application, flexible endoscpes generally have the same basic 
structure and function. There are three main components: the control section, the 
insertion tube, and the connector section [34].  The control section is where the operator 
can control the primary functions of the device such as, angulation of the instrument tip, 
suction, water flow, and image capture. Additionally, the control section provides the 
entry point for auxiliary tools. The insertion tube is a flexible shaft that allows passage of 
the auxiliary tools, as well as suction and fluids. Finally, the connector section attaches 
the endoscope to the electrical, CO2, air/water, and light sources [34]. The most critial 
feature of the flexible endoscope, as it relates to biofilm formation, is the suction/biopsy 
channel. The suction/biopsy channel is primarily used to remove blood and tissue. For 
this reason, it is the most likely component of the flexible endoscope for biofilm 
accumulation to occur. For the purpose of providing a first-level understanding of fluid 
dynamics through a flexible endoscope the suction/bpsy channel has been simplified 
into a smooth pipe model with one-dimensional flow, as shown in Figure 4.1.  
A principle mathematical property of flow dynamics s continuity, or conservation 
of the mass flow rate,M
•
The mass flow rate is a function of fluid density (ρ), velocity (v), 
and the cross-sectional area of the pipe (A). Where,  
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                                 (2) 
 
Conservation of mass flow states the rate of mass flow in is equal to the rate of mass flow 








Using Figure 4.1 as a model for one-dimensional flow through a suction/biopsy 
channel of a flexible endoscope in combination with reported inner diameter 
specifications and a volumetric flow rate from commercialized products a representative 
flow regime through a flexible endoscope channel can be characterized.  
To characterize the flow regime through the model channel, the flow velocity 
must first be determined. The fluid velocity is defin d as the volumetric flow rate divided 
by the cross sectional area of the channel,  
     V =
Q
A
                                                (4) 
where,





                                                   (5)
 
From Equations (2), (3), (4) and (5) the flow velocity an be derived. The fluid 
density and the diameter are constant throughout the pipe, therefore,  
                                                       Qin = vout Aout  (6) 













Figure 4.1: Schematic of blood flow through suction channel of flexible endoscope. 
In this model flow is one-dimensional, the pipe is smooth with a constant diameter, and 















From a design point, it is important to consider that decreasing the channel 
diameter of the scope is optimal for many minimally invasive procedures. Manufacturers 
of flexible endoscopes often have a product line of “slim” or “ultra slim” scopes where 
channel diameters specifications are altered to accmmodate more precise laparoscopic 
instrumentation.  To demonstrate the effect of diameter variations on fluid flow 
conditions a variety of endoscope diameters were incorporated into the model and 
mathematical equations to yield corresponding Reynolds numbers and flow regimes.  
Table 4.1 shows that for a constant volumetric flow rate, Q, as the inner diameter 
(ID) of the channel decreases by 3.8 mm, the Reynolds number increases by a factor of 
10. The flow regime produced by these conditions is turbulent. As noted by Pereira, et.al 
(2002) biofilms grown under turbulent flow tend to be denser and more strongly adhered 
to their substrate compared to biofilms grown under laminar flow [25]. Purevdorj, et.al 
(2002) also observed that turbulent biofilms tend to form large streamlined patches in a 
confluent monolayer with some filamentous streamers [35]. It is evident that under 
turbulent flow there is greater accumulation of biofilm [24,35]. Devices that are designed 
to meet a “slim” or “ultra slim” specification will typically operate under turbulent flow 
and, so, must also consider the resulting effects of biofilm accumulation.  
A simplified model facilitates the understanding of fluid dynamics through a 
straight channel. However, in reality flexible endosc pes are not rigid pipes. Their 
curvatures are complex, which is why they are such a allenge for reprocessing. An 
interesting study by Drescher, et.al (2012) illustrates how biofilm accumulation around 
corners can cause catastrophic disruptions of flow [36]. Using a model microfluidic flow 
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a system, Drescher, et.al (2012) showed that biofilm accumulation on pipe walls only 
marginally affects flow rate through the channel; however, biofilm streamers that form 
under turbulent flow around corners rapidly expand drastically impede flow [36].  
Rapidly expanding biofilm streamers in curved regions f a flexible endoscope has 
considerable consequences not only on the operating flow system, but also for cleaning 
during reprocessing.  
The complexity of biofilm hydrodynamics creates many questions for researchers 
as they seek to understand how biofilms change in varying environments. Fully 
understanding variation in biofilm structure continues to elude researchers, yet for many 
applications it will provide the answers needed for improving industrial systems. For 
reusable surgical instruments, specifically, it is evident that fluid flow phenomena 
impacts biofilm accumulation and, therefore, must be considered in the engineering 












Table 4.1: Variations in Reynolds number and flow regime with change in inner 
diameters in flexible endoscopes.  Inner diameters of instrument channels and  
suction/biopsy channels from a variety of commercially vailable flexible endoscopes 
[34] and a volumetric flow rate from a commercially available endoscopic suction pump 
[37] were used to determine variations in Reynolds number and flow regime. 
 
Constants ID (mm) ID (m) V (m/s) RE Regime 
Q [L/min] 20 4.8 4.8E-03 18.4 26677 Turbulent 
Density, Blood [Kg/m3] 1056 4.2 4.2E-03 24.1 30488 Turbulent 
Viscosity, Blood [Pa s] 3.5E-03 4.0 4.0E-03 26.5 32013 Turbulent 
    3.8 3.8E-03 29.4 33698 Turbulent 
    3.2 3.2E-03 41.4 40016 Turbulent 
    3.0 3.0E-03 47.2 42684 Turbulent 
    2.8 2.8E-03 54.1 45733 Turbulent 
    2.2 2.2E-03 87.7 58205 Turbulent 
    2.0 2.0E-03 106.1 64026 Turbulent 
    1.8 1.8E-03 131.0 71140 Turbulent 
    1.2 1.2E-03 294.7 106710 Turbulent 















Material characteristics, specifically surface roughness, are known to have an 
impact on biofilm accumulation. In this thesis, biofilm accumulation was quantified on 
four different materials with varying surface roughness (316L Stainless Steel= 0.372 µm, 
Polycarbonate= 0.01 µm, Polypropylene= 1.77 µm, and Silicone Rubber= 0.308 µm). It 
has been previously discussed that biofilm accumulation is greater for rough materials 
compared to smooth materials.  However, Wu et al. (2011) highlights, more specifically, 
the effect of surface texture on biofilm accumulation [31]. Wu, et al. investigated the 
differential response of S.epidermidis and osteoblasts to varying surface modifications to 
titanium femoral stems. Four different surface modifications with varying surface 
roughness were compared: polished (Ra=0.006 µm), satin (Ra = 0.830 µm), grit blasted 
(Ra =11 µm), and plasma sprayed (Ra=33 µm) (Figure 4.2).   
Using CLSM, Wu, et al. analyzed percent coverage of S.epidermidis on each 
substrate and found the satin finish had the highest p rcent coverage followed by grit-
blasted, plasma-sprayed, and then polished. Though the plasma sprayed finished was 
significantly rougher compared to the satin finish, Wu, et al. (2011) demonstrated that the 
surface texture profiles of these two finishes varied dramatically.  
The satin texture profile is macroscopically smooth, but microscopically has a 
lateral roughness profile with concave valleys thatincrease the bacteria-surface contact 
area [31]. In contrast, the plasma sprayed texture profile is very macroscopically rough 
with curvature profiles that are low and convex, which are considerably larger than the 
bacterial cell [31]. Essentially, Wu, et al. (2011) shows that bacterial adhesion increases 
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more when the surface texture profile is well matched to the bacteria morphology.  In his 
analysis of osteoblast response, Wu, et al. (2011) found contrasting behavior in the 
colonization of the osteoblasts. The osteoblasts demonstrated higher percent coverage on 
the plasma sprayed surface finish compared to the satin finish. Overall, the surface 
modifications vary in roughness, but it is the differences in the macroscopic and 
microscopic surface profiles that impact biofilm accumulation. 
Interested in biomaterials-associated infections as a leading failure mode of 
implants, Wu, et al. (2011) aimed to investigate the importance in roughness not only to 
osseointegration, but also to bacterial adhesion. Titanium surface modifications were 
originally incorporated into femoral stem design as a means to promote osseointgerance 
to preclude loosening and improve implant stability. Through his results, Wu et al. (2011) 
eloquently illustrated that design choices that are t geted towards improving device 
function and performance can have underlying implications for biofilm formation. 
Understanding the effect of design choices as an engin er must be well understood when 
designing reprocessed devices. 
In surgical instrumentation, surface texture can be integrated into the design to 
augment device performance and improve surgeon experi nc . For example, texture can 
be incorporated into ergonomic handle designs that feature more comfortable grips 
during long procedures [38]. Surface textures are known to improve grip for soft tissues, 
which is important for biopsy forceps [38].  Additionally, more dramatic texture 
modifications can increase tactical sensitivity between the surgeon’s hand and the 
instrument, which helps to reduce applied pressure to the surgical site [38]. For devices 
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that will be reused, it is imperative to fully understand the implications of texture and 
































Figure 4.2: Schematic of the texture profiles of four titanium surface modifications 
(adapted from Wu, et al. 2011) [31]. Polished is the smoothest (Ra=0.006 µm), followed 
























4.3 HUMAN AND ECONOMIC FACTORS FOR REPROCESSING REUSABLE 
MEDICAL DEVICES  
 
Human Factors  
When reprocessing reusable medical devices, human factors matter. As discussed 
in Chapter 1, OEMs are required by the FDA to provide validated reprocessing protocols 
and IFU documents for every reusable device. These IFUs are intended to provide 
detailed instructions according to standardized methods for how to reprocess the specific 
device. However, lack of specificity, complicated instructions and discrepancies from 
standardized methods have made it extremely difficult to follow manufacturers’ 
instructions [13]. The Central Sterile Processing Department at Johns Hopkins 
reprocesses at least 14,000 different reusable devices. Despite this large inventory, 
reprocessing technicians at that facility admit to working from memory or hearsay 
because of the confusing nature of the IFUs [13]. Despite that the FDA requires 
validation testing for human factors in reprocessing protocols, there is still cause for 
concern in the execution of reprocessing methods by the end-user.  In a recent study 
conducted by Jolly, et al. (2011) 24 nursing students were asked to reprocess an 
endoscope as an independent task using the manufacturer’s instructions. The study 
reported that none of the 24 participants were ableto r process the endoscope without 
error [39]. As the first published usability test [39] for reprocessing reusable medical 
devices, it clearly makes the point that there are human factors issues related to 
reprocessing. 
The focus of this thesis was to improve methods for validating cleaning protocols 
required for reprocessing. Recognizing that human factors do matter in reprocessing, an 
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effective method that could provide simple and high-throughput verification testing of 
cleaning was investigated. The colorimetric assay holds value in its ability to provide a 
simple “yes” or “no” detection of biofilm accumulation, while also being easy to execute. 
Jolly, et al. (2011) determined that one of the thre reasons for the observed error in 
reprocessing was inconsistent or lack of feedback [39]. Participants reported that they had 
no way of knowing if what they were doing was correct.  Essentially, there were no 
feedback controls in place. A potential industry application for the colorimetric assay is a 
system control for ensuring adequacy in cleaning by providing real time feedback. 
Current validation methods require intensive, expert-level methodology such as soil 
extraction from the device and subsequent fluorescent imaging or biochemical testing or 
direct testing of the soil on the device using radionuclide sampling [13]. For a central 
sterile supply unit reprocessing 14,000 devices, for example, this type of methodology 
simply is not feasible in real-time. The industry is currently calling for improved methods 
in detecting bioburden on reusable devices [13,14]. In this regard, a simplistic approach is 
what is needed to address the human factors issues that are a primary cause of improper 
reprocessing.  
 
Economic Factors  
As discussed in Chapter 1, the economics of reprocessing are not favorable for 
OEMs’ business needs.  OEMs are held to high standards for producing validation testing 
for a process that actually results in decreased profit margins for the product due to 
reductions in repurchase by the end-user. The specialized equipment and materials 
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required for the validation testing are not capital the OEM sees as a worthwhile 
investment, as a result, this type of testing is typically contracted out. Contract testing can 
quickly become very expensive. Moreover, FDA guidelines strongly suggest destruction 
testing for devices with small lumens or tight interfaces to ensure adequate cleaning [14]. 
This is another loss of revenue for the OEM. The loss f revenue combined with the high 
costs associated with rigorous validation testing required for reprocessing makes medical 
device reprocessing an unfavorable economic business model for OEMs. Recognizing the 
cost associated with reprocessing for the manufacturer, this research sought to develop a 
cost-effective method for detecting biofilm accumulation on reusable medical devices. 
Providing a cost-effective method for OEMs to implement during validation testing 
would reduce the economic burden on OEMs and likely improve the validation data 
required for proving safety and effectiveness of reprocessing protocols.  
The studies presented in this thesis implemented both a colorimetric assay and 
confocal laser scanning microscopy (CLSM) for quantifyi g biofilm accumulation on 
medical device materials. A comprehensive evaluation of the costs associated with the 
experimental work for both methods (as presented in Chapters 2 and 3) was conducted to 
provide a realistic valuation of each method. The objective of this analysis was to 
characterize the cost-effectiveness of both the colorimetric assay and CLSM.   
Several assumptions were included in the cost analysis. 1) A confocal microscope 
would not be purchased as a capital expense for the CLSM method. A conservative cost 
estimate for a confocal microscope is on the order of $100,000. In addition to the capital 
cost of a confocal microscope, recurring costs for maintenance and operation would make 
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this an impractical purchase for an OEM (Table 4.2). 2) A single experiment, n, 
represents the analysis of eight coupons (Table 4.4). 3) The number of experiments 
conducted in one year is 50 (Table 4.5). This was determined by the live/dead assay. 
When stored according to manufacturer’s instructions the live/dead assay will remain 
stable for on year. The total number of reactions that live/dead assay can yield is 100 and 
the number of reactions required by each experiment is two. For this reason, it was 
assumed the live/dead assay could sustain 50 experiments in one year. 4) The rinse 
beakers used in the CV assay were a reusable item that could sustain a maximum of 10 
experiments (Table 4.5). 5) Price fluctuation and inflation were not considered for 
projected yearly costs (Table 4.6).  
Based on the expenditures related to each method for both capital and recurring 
costs, a significant cost differential between these two test methods was observed. The 
cost per experiment for the colorimetric assay was $23.56, while the cost per experiment 
for CLSM was $259.31 (Table 4.4). The contract time for using the confocal microscope 
was the largest contributing cost for the CLSM analysis method, comprising 96% of the 
total cost experimental cost. Despite the capital expense of the microplate 
spectrophotometer required by the colorimetric assay, this method yielded a yearly 
savings in year one of 27% (Table 4.6). In year two, the colorimetric assay yielded a 
yearly savings of 96% (Table 4.6). It is clear that the colorimetric assay is significantly 
more cost effective compared to CLSM. The low cost as ociated with the colorimetric 
assay enhances its potential for an industry relevant method used for verification and 
validation testing required for medical device reprocessing.  
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Table 4.2 Capital expenditures. Capital expenditures included only a microplate 
spectrophotometer (Epoch™, BioTek® Instruments, Inc., Winooksi, VT) required for 
absorbance analysis as apart of the CV assay method. Price determined from scientific 








Table 4.3 Recurring costs. Recurring costs were calculated for all items required to 
conduct each method. Units and bulk costs were determin d from purchase orders made 
during experimental work. Contract time for using the confocal microscope was 
determined from the rates established by the Clemson Light Imaging Facility for non-




Item Unit Bulk Cost Cost Per Unit 
Crystal Violet Stain  Bottle (500 mL) $14.28 $0.03 
200 μl Pipette Tips Box-960 tips $59.30 $5.93 
Acetic Acid 2500 mL $34.36 $0.01 
Staining Reservoirs 100pk $58.72 $0.59 
Rinse Beakers  100pk $46.41 $0.46 
CLSM 
Item Unit Bulk Cost Cost Per Unit 
L/D Assay 100 reactions $354.00 $3.54 
PTFE Tape 1 roll $3.92 $3.92 
Valup 1 vial $50.00 $2.50 
Contract Time 1 hour $125.00 $125.00 
 





Table 4.4 Total cost per experiment (n=1). The total cost per experiment was 
determined from the number of units required to analyze eight coupons (with an error 
factor) and the cost per unit (Table 4.3) For example, for eight coupons only 48 mL of 















Item Units Used Per Experiment Cost Per Experiment 
Crystal Violet Stain  32 mL $0.91 
200 μl Pipette Tips 1 box $5.93 
Acetic Acid 50 mL $0.69 
Staining Reservoirs 2 reservoirs $1.17 
Rinse Beakers  32 beakers $14.85 
TOTAL   $23.56 
CLSM 
Item Units Used Per Experiment Cost Per Experiment 
L/D Assay 2 reactions $7.08 
PTFE Tape 1/4 roll  $0.98 
Valup 1/2 vial $1.25 
Contract Time 2 hours $250.00 
TOTAL   $259.31 
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Table 4.5 Total cost per year (n=50). The total cost per year for each method was 
calculated for the number of units of each item required to conduct 50 experiments. Only 
160 rinse beakers were needed for one year because rinse beakers are a reusable item. It 
was determined that if the beakers were properly cleaned and maintained between each 
experiment they could be used for a maximum of 10 experiments.   
 
 
Table 4.6 Projected yearly savings. Percent savings was calculated for year one, which 
included the capital expenditures. It was assumed all capital expenditures would be paid 
in year one and would not carry over into year two. It was also assumed that all yearly 







Method Year 1 Year 2 
COLORIMETRIC ASSAY $9,459.52 $509.52 
CLSM $12,965.50 $12,965.50 
Percent Savings (%) 27.0 96.1 
COLORIMETRIC ASSAY 
Item Units Used Per Experiment 
Cost Per 
Unit Units Needed for 1 Year 
Cost Per 
Year 
Crystal Violet Stain  32 mL $0.03 1,600 mL $45.68 
200 μl Pipette Tips 1 box $5.93 50 boxes $296.50 
Acetic Acid 50 mL $0.01 2,500 mL $34.36 
Staining Reservoirs 2 reservoirs $0.59 100 reservoirs $58.72 
Rinse Beakers  32 beakers $0.46 160 beakers $74.26 
TOTAL       $509.52 
CLSM 
Item Units Used Per Experiment 
Cost Per 
Unit Units Needed for 1 Year 
Cost Per 
Year 
L/D Assay 2 reactions $3.54 100 reactions $354.00 
PTFE Tape 1/4 roll  $3.92 12.5 rolls $49.00 
Valup 1/2 vial $2.50 25 vials $62.50 
Contract Time 2 hours $125.00 100 hours $12,500.00 
TOTAL       $12,965.50 
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4.4 CONCLUSION  
The broad objective of this chapter was to demonstrate both the engineering and 
commercial significance of the research work presented in this thesis. From an 
engineering perspective, reprocessing of reusable medical devices is a complex process 
that requires careful consideration of device design.  Device geometry, fluid flow 
principles, and material selection and surface characte istics are all engineering factors 
that can have a significant impact on biofilm accumulation and, subsequently, effective 
device reprocessing. From a commercial perspective, human factors and cost matter in 
medical device reprocessing. In order to sustain quality control in reprocessing of 
medical devices it is critical for reprocessing methods to not only be repeatable and 
reproducible, but to be easily monitored and traceable. The unique economic model of 
medical device reprocessing places a financial burden on OEMs. For this reason, a cost-
efficient method for validation testing for cleaning methods is necessary for improving 
reprocessing outcomes.  
Safe and effective reprocessing is a result of many co tributing factors: device 
design, improved verification and validation methods for cleaning, IFUs that consider 
human factors, and cost. In an effort to improve the engineering and commercial 
considerations related to reprocessing, this work delivered a simple, cost-efficient method 
suitable for detecting biofilms on complex reusable m dical devices in a high-throughput 
industry setting for the purpose of validating cleaning methods required for reprocessing 
CHAPTER FIVE 
CONCLUSION 
Challenges associated with improper reprocessing are related to the complexity of 
reusable medical device design, validation of cleaning protocols required by the FDA, as 
well as human and economic factors. The broad objective of this thesis was to deliver a 
simple, cost-efficient method suitable for detecting biofilms on complex reusable medical 
devices in a high-throughput industry setting for the purpose of validating cleaning 
methods required for reprocessing. 
Current methods for detecting biofilm accumulation on medical devices are 
established; however, these methods lack appropriate consideration for the complex 
design features of reusable medical devices.  A colorimetric assay widely used for 
quantifying biofilm accumulation is suitable for the complexity of reusable medical 
devices; however, its application has been limited to biofilms grown in a tissue culture 
plate, which does not accurately represent the true g owth conditions of biofilm. 
Modifications of this colorimetric assay were necessary to appropriately stain biofilm 
grown on large surface areas. Experimental work confirmed a 6 mL volume of acetic acid 
and a 570 nm excitation wavelength together provided a highly sensitive detection 
method for biofilms stained with CV. The high sensitivity of this colorimetric assay 
makes it ideal for detecting biofilm on reusable medical devices with complex design 
features.  
A current, standard method for detecting biofilm accumulation, CLSM, can 
provide accurate quantitative data through imaging processing techniques. Experimental 
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work demonstrated that pixilation intensities of biofilm with fluorescent staining can be 
quantified using image-processing software, such as Im ge J. Comparing intensity ratios 
and absorbance measurements from the colorimetric assay for a given biofilm could 
demonstrate a direct relationship between the two detection modalities effectively 
validating the modified colorimetric assay as a method for detecting biofilm 
accumulation on reusable medical devices.  
Once validated, the modified colorimetric assay has potential for becoming an 
industry relevant method for improving medical devic  reprocessing outcomes. The 
industry is currently calling for improved methods in detecting bioburden on reusable 
devices. The colorimetric assay provides highly sensitivity detection of biofilm and is 
applicable to devices with complex designs. Additionally, it is a simplistic approach to 
validating cleaning protocols required by the FDA, which is what is needed to address the 
human factors issues that are a primary cause of improper reprocessing. Finally, the 
modified colorimetric assay improves the financial burden incurred by OEMs by 
providing yearly cost savings of 96% when used as avalidation method instead of 
conventional confocal microscopy. Reducing costs associated with reprocessing creates 
an incentive for OEMs to improve device designs for reprocessing and produce feasible 
reprocessing protocols that can be adequately executed in an industrial system. 
In conclusion, this thesis presents a modified colorimetric assay for detecting 
biofilm accumulation on reusable medical devices that offers an innovative solution to 




























RAW DATA FOR STATISTICAL ANALYSIS  
 
Table A.1 Absorbance data and contributing effects variables. Data were analyzed 
using a generalized linear model and a binomial distribution to test for the effects of 
material, inoculum concentration, flow conditions, channel position, wavelength, and 















































1 SS 10.3 3 20 0.069   
1 SS 10.3 5 20 0.547   
2 SS 9.9 2 20 0.173   
2 SS 9.9 5 20 0.351   
3 SS 5.3 4 20 0.215   
3 SS 5.3 5 20 0.415   
4 SS 9.7 1 20 0.135   
4 SS 9.7 5 20 0.519   
5 SS 9.1 3 20 0.204   
5 SS 9.1 5 20 0.136   
4 SS 9.7 1 20   0.717 
4 SS 9.7 5 20   3.454 
5 SS 9.1 3 20   1.469 
5 SS 9.1 5 20   0.998 
1 PC 10.3 2 20 0.091   
1 PC 10.3 5 20 0.114   
2 PC 9.9 1 20 0.145   
2 PC 9.9 5 20 0.134   
3 PC 5.3 3 20 0.179   
3 PC 5.3 5 20 0.095   
4 PC 9.7 4 20 0.055   
4 PC 9.7 5 20 0.551   
5 PC 9.1 2 20 0.048   
5 PC 9.1 5 20 0.129   
4 PC 9.7 4 20   0.137 
4 PC 9.7 5 20   3.52 
5 PC 9.1 2 20   0.124 
5 PC 9.1 5 20   0.823 
2 PP 10.3 5 20 0.157   
2 PP 9.9 4 20 0.151   
2 PP 9.9 5 20 0.344   
3 PP 5.3 2 20 0.211   
3 PP 5.3 5 20 0.064   
4 PP 9.7 3 20 0.263   
4 PP 9.7 5 20 0.375   
5 PP 9.1 1 20 0.185   
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5 PP 9.1 5 20 0.175   
4 PP 9.7 3 20   1.668 
4 PP 9.7 5 20   2.634 
5 PP 9.1 1 20   1.718 
5 PP 9.1 5 20   1.508 
1 SI 10.3 4 20 0.197   
1 SI 10.3 5 20 0.453   
2 SI 9.9 3 20 0.316   
2 SI 9.9 5 20 0.167   
3 SI 5.3 1 20 0.459   
3 SI 5.3 5 20 0.064   
4 SI 9.7 2 20 0.191   
4 SI 9.7 5 20 0.107   
5 SI 9.1 4 20 0.05   
5 SI 9.1 5 20 0.075   
4 SI 9.7 2 20   1.086 
4 SI 9.7 5 20   0.528 
5 SI 9.1 4 20   1.469 
5 SI 9.1 5 20   0.375 
6 SS 9.4 2 6 0.583   
6 SS 9.4 5 6 0.445   
7 SS 5.4 4 6 0.307   
7 SS 5.4 5 6 2.375   
6 PC 9.4 1 6 0.187   
6 PC 9.4 5 6 0.234   
7 PC 5.4 3 6 0.094   
7 PC 5.4 5 6 0.849   
6 PP 9.4 4 6 0.275   
6 PP 9.4 5 6 0.374   
7 PP 5.4 2 6 0.120   
7 PP 5.4 5 6 1.134   
6 SI 9.4 3 6 0.156   
6 SI 9.4 5 6 0.111   
7 SI 5.4 1 6 0.065   
7 SI 5.4 5 6 0.107   
6 SS 9.4 2 6   3.650 
6 SS 9.4 5 6   3.466 
7 SS 5.4 4 6   2.721 
7 SS 5.4 5 6   3.987 
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6 PC 9.4 1 6   1.306 
6 PC 9.4 5 6   2.225 
7 PC 5.4 3 6   0.484 
7 PC 5.4 5 6   3.646 
6 PP 9.4 4 6   1.962 
6 PP 9.4 5 6   3.355 
7 PP 5.4 2 6   0.895 
7 PP 5.4 5 6   3.702 
6 SI 9.4 3 6   0.878 
6 SI 9.4 5 6   0.800 
7 SI 5.4 1 6   0.275 































































Figure B.1 Drip flow reactor set-up inside incubator. Flow of TSB is delivered in 
silicone tubing to each channel through the influent mininert valve and 21-gauge needle. 
Reactor is positioned at a 10-degree angle, which provides gravitational fluid flow over 






























Figure B.2 Laboratory set-up of peristaltic pump system and drip flow reactor. 
Peristaltic pump system delivers flows of 3 g/L TSB media from inlet media carboy to 




















































            AA: acetic acid 
Figure B.3 Illustration of CV staining on coupons and corresponding CV solutions 
in a 96- well plate.  (A-D): Biofilms grown in DFR, (E-H): DFR biofilms stained with 
crystal violet, (I-L): Biofilms grown statically, (M-P): Static biofilms stained with 
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